Analysis: Warsh rate hike reinforces Fed independence after Trump pressure Americans' incomes rose and poverty fell in 2025, Census Bureau says OpenAI CFO Sarah Friar emphasizes 'need to take safety seriously' on AI risks Elon Musk, the world’s richest man, says he’s living in an Airstream trailer to oversee xAI’s biggest expansion yet Dominant Kerr wins $150K with GB's first Ultimate title Amid war and sanctions, many Iranians are losing their jobs and struggling to get by Dan Chung rebuilt a decimated Alger Management after 9/11. He's still finding the market's winners Kenya's foreign trader crackdown sparks fear among migrant communities OpenAI says it cracked one of math’s grand challenges. But there are troubling questions about how they did it—and what it means for us all U.S. debt is even worse than it seems, and rising Treasury yields are now an ‘all-hands-on-deck situation,’ top economist warns

Robert Duggan

Robert Duggan

Robert Duggan (#235)

Global Rank #235
Country Rank #100
Country United States

Robert Duggan is listed among the world billionaires tracked by Iconic Billionaires.

  • $ 14 B
  • Pharmaceuticals
  • United States
  • M
  • 82 Years

Snapshot

Quick Facts

Global Rank #235
Country Rank #100
Net Worth $13.5B
Previous Worth $13.1B
Worth Change +$0.4B
Country United States
Industry Pharmaceuticals
Age 82 Years
Gender M
Worth As Of May 4, 2026
Last Refreshed 07 Sep 2026, 12:00 AM
Residence Miami, Florida
World Billionaires List United States Billionaires Pharmaceuticals

Profile Data

Personal Stats

Age 82
Source Of Wealth Pharmaceuticals, Self Made
Self Made Score 8
Residence Miami, Florida
Citizenship United States
Marital Status Married
Children 8
Education Drop Out, University of California, Los Angeles; Drop Out, University of California, Santa Barbara
Net Worth Change +$0.4B +3.1% from previous worth
Previous Net Worth $13.1B
Current Net Worth $13.5B

Worth as of May 4, 2026

About Me

In 2020, Robert Duggan invested $63 million in Nasdaq-listed Summit Therapeutics and became its Co-CEO, leading the biotech in developing targeted oncology therapies for difficult diagnoses. Pharmacyclics' cancer drug Imbruvica made Duggan a billionaire in 2013 and paved the way for the company's $21 billion sale to AbbVie in 2015. Duggan, whose son died from brain cancer, became passionate about Pharmacyclic's cancer fighting drugs and first invested in 2004. His enthusiasm for investing began four decades earlier in a corporate finance class he took at the University of California at Santa Barbara. In 2020, Duggan bought $63 million of shares in Nasdaq-listed Summit Therapeutics, a small biotech company, and became its CEO. Duggan also sits on the board of Pulse Biosciences, of which he is the largest individual shareholder.

Insights

Did You Know?

Duggan is a big donor to the Church of Scientology, of which he is a member; he says he's given the church nearly $360 million over his lifetime.

Duggan enjoys surfing in his spare time.

Wealth Growth

Net Worth Growth Over Time

Tracking Robert Duggan's net worth journey over the years, highlighting key growth phases and financial milestones.

Worth Trend Net Worth Growth
Period Change Worth Movement
Current Net Worth: $13.5B (May 4, 2026)

© Iconic Billionaires